Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine

References

• AcanforaDGheorghiadeMTrojanoL2004A randomized, double-blind comparison of lercanidipine 10 and 20 mg in patients with stable effort angina: clinical evaluation of cardiac function by ambulatory ventricular scintigraphic monitoringAm J Ther114233215543081
   PubMed Web of Science ®Google Scholar
• AgrawalRMarxAHallerH2006Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertensionJ Hypertens241859216331117
   PubMed Web of Science ®Google Scholar
• AmbrosioniELeonettiGPessinaARappelliATrimarcoB2000Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapyJ Hypertens181691911081785
   PubMed Web of Science ®Google Scholar
• AngelicoPGuarnieriNLeonardiA1999Vascular-selective effect of leranidipine and other 1,4 dihydropyridines in isolated rabbit tissuesJ Pharm Pharmacol517091410454048
   PubMed Web of Science ®Google Scholar
• ArimaSItoSOmataK1996Role of actions of calcium antagonists on efferent arterioles with special references to glomerular hypertensionAm J Nephrol2322944
   Google Scholar
• BangLMChapmanTMGoaKL2003Lercanidipine: a review of its efficacy in the management of hypertensionDrugs6324497214609358
   PubMed Web of Science ®Google Scholar
• BarriosVEscobarCde la FigueraM2008Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE studyCardiovasc Ther262918466416
   PubMed Web of Science ®Google Scholar
• BarriosVNavarroAEsterasA2002Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE study. Eficacia de Lercanidipino y su Perfil de SeguridadBlood Press119510012035878
   PubMed Web of Science ®Google Scholar
• BasileJ2004The role of existing and newer calcium channel blockers in the treatment of hypertensionJ Clin Hypertens66219
   PubMedGoogle Scholar
• BloomBS1998Continuation of initial antihypertensive medication after 1 year of therapyClin Ther20671819737827
   PubMed Web of Science ®Google Scholar
• BorghiC2005Lercanidipine in hypertensionVasc Health Risk Manag11738217319103
   PubMedGoogle Scholar
• BorghiCPrandinMGDormiAAmbrosioniEStudy group of the regional Unit of the Italian Society of Hypertension2003 Improved Tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trialBlood Press Suppl1142112800983
   PubMedGoogle Scholar
• BurnierMGasserUE2007Efficacy and tolerability of lercanidipine in patients with hypertension: results of a Phase IV study in general practiceExpert Opin Pharmacother822152317927478
   PubMed Web of Science ®Google Scholar
• BurnierMSantschiVFavratBBrunnerHR2003Monitoring compliance in resistant hypertension: an important step in patient managementJ Hypertens21S3742
   PubMed Web of Science ®Google Scholar
• BurnierMHessBGremingerPWaeberB2005Determinants of persistence in hypertensive patients treated with Irbesartan: results of a postmarketing surveyBMC Cardiovasc Disords513
   PubMedGoogle Scholar
• FogariRMugelliniAZoppiA2003Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertensionAm J Hypertens16135769
   Web of Science ®Google Scholar
• CaroJJSpeckmanJLSalasM1999Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice dataCMAJ1604169934342
   PubMed Web of Science ®Google Scholar
• CleophasTJvan OuwekerkBMvan der MeulenJ2001Diabetics with hypertension not controlled with ACE-inhibitors: alternate therapiesAngiology524697511515986
   PubMed Web of Science ®Google Scholar
• CollinsORPetoR1994Antihypertensive drug therapy: effects on stroke and coronary heart diseaseSwalesJDTextbook of HypertensionOxford, EnglandBlackwell Scientific Publications115664
   Google Scholar
• CroogSHLevineSTestaMA1986The effects of antihypertensive therapy on the quality of lifeN Engl J Med3141657643520318
   PubMed Web of Science ®Google Scholar
• DahlöfBSeversPSPoulterNR2005Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering arm (ASCOT-BPLA): a multicentre randomized controlled trialLancet36689590616154016
   PubMed Web of Science ®Google Scholar
• DeGiorgioLAOrlandiniFMalasomaPZappaA1999Double blind, cross-over study of lercanidipine versus amlodipine in the treatment of mild to moderate essential hypertensionCurr Ther Res6051120
   Web of Science ®Google Scholar
• DouglasJGAgodoaL2003ACE-inhibition is effective and renoprotective in hypertensive nephrosclerosis: the African American Study of Kidney Disease and Hypertension (AASK) trialKidney Int Suppl83S74612864879
   PubMedGoogle Scholar
• GrandiAMSolbiatiFLauritaE2008Effects of dual blockade of reninangiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot studyAm J Hypertens21231718174880
   PubMed Web of Science ®Google Scholar
• GressTWNietoFJShaharE2000Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis risk in communities studyN Engl J Med139051210738048
   PubMedGoogle Scholar
• GuillenVGAbellanJLlisterriJL2003Efficacy and safety of lercanidipine in combination with enalapril in HBP. Preliminary results of ZANYCONTROL study groupAm J Hypertens16115A
   Web of Science ®Google Scholar
• GuptaAKDahlöfBDobsonJ2008Determinants of new-onset diabetes among 189,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm and the relative influence of antihypertensive medicationDiabetes Care31982818235048
   PubMed Web of Science ®Google Scholar
• HairPIScottLJPerryCM2007Fixed-dose combination lercanidipine/enalaprilDrugs679510617209666
   PubMed Web of Science ®Google Scholar
• HajjarIKotchenTA2003Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000JAMA29019920612851274
   PubMed Web of Science ®Google Scholar
• HerbetteLGVecchiarelliMSartaniALeonardiA1998Lercanidipine: short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular models to rationalize its pharmacokinetic propertiesBlood Press Suppl21079850437
   PubMedGoogle Scholar
• HollenbergNK2002Observations on the safety of lercanidipine: adverse events from placebo-controlled trialsAm J Hypertens1558A59A11824862
   PubMed Web of Science ®Google Scholar
• Joint National Committee on Prevention, Detection Evaluation and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordination CommitteeThe Sixth Report of the Joint National Committee on Prevention, Detection Evaluation and Treatment of High Blood Pressure1997Arch Intern Med1572413469385294
   PubMed Web of Science ®Google Scholar
• JonesJKGorkinLLianJF1995Discontinuation of and changes in treatment after start of new courses of antihypertensiv drugs: a study of a United Kingdom populationBMJ31129357633238
   PubMed Web of Science ®Google Scholar
• KruseWWeberE1990Dynamics of drug regimen compliance-its assessment by microprocessor-based monitoringEur J Clin Pharmacol3856152373129
   PubMed Web of Science ®Google Scholar
• Loghman-AdhamM2003Medication Noncompliance in patients with chronic disease: issues in dialysis and renal transplantationAm J Manag Care91557112597603
   PubMed Web of Science ®Google Scholar
• ManciaGDe BackerGuyDominiczakA2007Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens2511058717563527
   PubMed Web of Science ®Google Scholar
• MasonJMDickinsonHONicolsonDJ2005The diabetogenic potential of thiazide-diuretic and beta blocker combinations in patients with hypertensionJ Hypertens23177981
   Web of Science ®Google Scholar
• Morb Mortal Wkly Rep (MMWR)2005Racial/ethnic disparities in prevalence, treatment, and control of hypertension – United States 1999–2002MMWR5479
   PubMedGoogle Scholar
• MorganSGYanL2004Persistence with hypertension treatment among community-dwelling BC seniorsCan J Clin Pharmacol1126773
   Google Scholar
• NedeltchevKArnoldMBaumgartnerR2005Vascular risk factors in the Swiss populationJ Neurol2521210615827865
   PubMed Web of Science ®Google Scholar
• NueschRSchroederKDieterleT2001Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control studyBr Med J323142611463685
   PubMedGoogle Scholar
• PedrinelliRDell’OmoGNutiM2003Heterogeneous effect of calcium antagonists on leg oedema: a comparison of amlodipine versus lercanidipine in hypertensive patientsJ Hypertens2119697314508205
   PubMed Web of Science ®Google Scholar
• PonceletPRibsteinJGoullardL2004Efficacy and acceptability of lercanidipine are not age dependent in patients with essential hypertension: the AGATE studyAnn Cardiol Angeiol5312330
   PubMedGoogle Scholar
• PoluzziEStrahinjaPVargiuA2005Initial treatment of hypertension and adherence to therapy in general practice in ItalyEur J Clin Pharmacol61603916082539
   PubMed Web of Science ®Google Scholar
• PuigJGCalvoCLuurilaO2007Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive patients: placebo-controlled, randomized, crossover study with four ABPMJ Hum Hypertens219172417581601
   PubMed Web of Science ®Google Scholar
• PullarTKumarSFeelyM1989Compliance in clinical trialsAnn Rheum Dis4887152684057
   PubMed Web of Science ®Google Scholar
• RoblesNROconJGomezCF2005Lercanidipine in patients with chronic renal failure: the ZAFRA studyRen Fail1738015717638
   PubMedGoogle Scholar
• SabbatiniMLeonardiATestaR2000Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive ratsHypertension35775910720594
   PubMed Web of Science ®Google Scholar
• SasakiTMaruyamaHKaseY2005Antianginal effects of lercanidipine on the vasopressin or metacholine induced anginal models in ratsBiol Pharm Bull28811615863884
   PubMed Web of Science ®Google Scholar
• ShulmanNCutterGDaughertyR1982Correlates of attendance and compliance in the hypertension detection and follow-up programControl Clin Trials313277067470
   PubMedGoogle Scholar
• SimonsLAOrtizMCalcinoG2008Persistence with antihypertensive medication: Australia-wide experience 2004–6Med J Aust188224718279129
   PubMed Web of Science ®Google Scholar
• SironiGMontagnaEGretoL1996Haemodynamic effects of lercanidipine in anaesthetized open-chest dogsArzneimittelforschung46256618901145
   PubMed Web of Science ®Google Scholar
• TakabatakeTOhtaHSasakiT1993Renal effects of manidipine hydrochloride: a new calcium antagonist in hypertensive patientsEur J Clin Pharmacol198516
   Google Scholar
• The ALLHAT officers and coordinators for the ALLHAT collaborative research groupMajor outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT)2002JAMA28829819712479763
   PubMed Web of Science ®Google Scholar
• UrquhartJVrijensB2005New findings about patient adherence to prescribed drug dosing regimens: an introduction to pharmionicsEur J Hospital Pharm Sci111036
   Google Scholar
• VerdecchiaPReboldiGAngeliF2005Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke preventionHypertension463869216009786
   PubMed Web of Science ®Google Scholar
• VeronesiMCiceroAFPrandinMG2007A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practiceVasc Health Risk Manag3999100518200818
   PubMedGoogle Scholar
• VoyakiSMStaessenJAThijsL2001Follow-up of renal function in treated and untreated older patients with isolated systolic hypertensionJ Hypertens19511911288822
   PubMed Web of Science ®Google Scholar
• VrijensBVinczeGKristanoP2008Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing historiesBMJ3361114718480115
   PubMed Web of Science ®Google Scholar
• WaeberBBurnierMBrunnerHR1999Compliance with antihypertensive treatmentClin Exp Hypertens219738510423118
   PubMed Web of Science ®Google Scholar
• WeirMRMoserM2000Diuretics and beta-blockers: is there a risk for dyslipidemia?Am Heart J1391748310618579
   PubMed Web of Science ®Google Scholar
• World Health Organization: Adherence to long-term therapiesEvidence for action2003GenevaWorld Health Organization URL: http://www.who.int/chronic_conditions/adherencereport/en/index.html.
   Google Scholar